Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACiE for locally advanced gastric cancer
NCT05346874Phase 2Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, tegafur in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
oxaliplatintegafur
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT05346874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05346874.